American Journal of Neuroradiology, Vol 19, Issue 3 477-484, Copyright © 1998 by American Society of Neuroradiology
ARTICLES |
MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations
RK Fulbright, JC Chaloupka, CM Putman, GK Sze, MM Merriam, GK Lee, PB Fayad, IA Awad and RI White Jr
Department of Neuroradiology, Yale University School of Medicine, New Haven, Conn 06520, USA.
PURPOSE: Our goal was to describe the prevalence and types of cerebral vascular malformations (CVMs) seen with MR imaging in patients with hereditary hemorrhagic telangiectasia (HHT). METHODS: We reviewed retrospectively the brain MR images of 184 consecutive patients with HHT. Catheter angiography was performed in 17 patients with CVMs detected on MR images. RESULTS: MR imaging revealed 63 CVMs in 42 patients. Classic arteriovenous malformations (n = 10) had a conspicuous network of vessels with flow voids and enlarged adjacent pial vessels. Apparent venous malformations (n = 5) were best seen after administration of contrast material as a prominent vessel coursing through normal brain parenchyma. Indeterminate vascular malformations (n = 48) had a spectrum of appearances characterized by variable combinations of heterogeneous signal intensity, enhancement, or hemosiderin. Angiography in 17 patients revealed 47 CVMs. Forty-six were arteriovenous malformations (AVMs), including 25 CVMs not seen with MR imaging and 21 CVMs that by MR criteria included 8 AVMs and 13 indeterminate vascular malformations. Angiography confirmed 1 venous malformation seen with MR imaging but failed to detect 3 indeterminate lesions revealed by MR imaging. CONCLUSION: MR imaging of a large cohort of consecutive patients with HHT revealed a CVM prevalence of 23% (42/184). Most CVMs (48/63) have an atypical appearance for vascular malformations on MR images. Angiographic correlation suggests that MR imaging underestimates the prevalence of CVMs and that the majority of indeterminate CVMs, despite their variable MR appearance, are AVMs.
This article has been cited by other articles:
 |
|
 |
|
  F. Gedge, J. McDonald, A. Phansalkar, L.-S. Chou, F. Calderon, R. Mao, E. Lyon, and P. Bayrak-Toydemir Clinical and Analytical Sensitivities in Hereditary Hemorrhagic Telangiectasia Testing and a Report of de Novo Mutations J. Mol. Diagn., April 1, 2007; 9(2): 258 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sabba, G. Pasculli, P. Suppressa, F. D'Ovidio, G. M. Lenato, F. Resta, G. Assennato, and G. Guanti Life expectancy in patients with hereditary haemorrhagic telangiectasia QJM, May 1, 2006; 99(5): 327 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T G W Letteboer, J J Mager, R J Snijder, B P C Koeleman, D Lindhout, J K Ploos van Amstel, and C J J Westermann Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia J. Med. Genet., April 1, 2006; 43(4): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jaskolka, L. Wu, R. P. Chan, and M. E. Faughnan Imaging of Hereditary Hemorrhagic Telangiectasia Am. J. Roentgenol., August 1, 2004; 183(2): 307 - 314. [Full Text] [PDF]
|
|
|
|
|
|
S A Abdalla, U W Geisthoff, D Bonneau, H Plauchu, J McDonald, S Kennedy, M E Faughnan, and M Letarte Visceral manifestations in hereditary haemorrhagic telangiectasia type 2 J. Med. Genet., July 1, 2003; 40(7): 494 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J Easey, G M F Wallace, J M B Hughes, J E Jackson, W J Taylor, and C L Shovlin Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 743 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Satomi, R. J. Mount;, M. Toporsian, A. D. Paterson, M. C. Wallace, R. V. Harrison, and M. Letarte Cerebral Vascular Abnormalities in a Murine Model of Hereditary Hemorrhagic Telangiectasia Stroke, March 1, 2003; 34(3): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M E Begbie, G M F Wallace, and C L Shovlin Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century Postgrad. Med. J., January 1, 2003; 79(927): 18 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Cloft Spontaneous Regression of Cerebral Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 1049 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mandzia, K. Henderson, M. Faughnan, R. White Jr, C. O. Maher, D. G. Piepgras, R. D. Brown Jr, J. A. Friedman, and B. E. Pollock Compelling Reasons to Screen Brain in HHT Response Stroke, December 1, 2001; 32(12): 2957 - 2958. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Al-Shahi and C. Warlow A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults Brain, October 1, 2001; 124(10): 1900 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. O. Maher, D. G. Piepgras, R. D. Brown Jr, J. A. Friedman, and B. E. Pollock Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia Stroke, April 1, 2001; 32(4): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsubara, J. L. Manzia, K. ter Brugge, R. A. Willinsky, W. Montanera, and M. E. Faughnan Angiographic and Clinical Characteristics of Patients with Cerebral Arteriovenous Malformations Associated with Hereditary Hemorrhagic Telangiectasia AJNR Am. J. Neuroradiol., June 1, 2000; 21(6): 1016 - 1020. [Abstract] [Full Text]
|
|